Drug Information Association Logo
Corporate Tagline

Bridging the Gap Between Strategy and Execution

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 24, 2:30PM - 4:00PM

Session Number:
128

Room Number:
104C

Level:
Intermediate

Type:
Symposium

Title:
Bridging the Gap Between Strategy and Execution

Chair(s):
Akhil Agrawal, PhD,PMP
Associate Director
Merck Research Laboratories, United States

Description:
This symposium will explore ways to bridge the gap between strategy and execution. The importance of an effective link between strategy and execution, or simply “Strategy=Execution,” is also becoming increasingly important in the pharmaceutical and biotechnology industry due to the increasing pressure on costs and timelines. Moreover, it can help ensure innovation occurs not only during discovery of new products, but also during strategic planning and execution. This symposium will highlight a few case studies and will share real life best practices and lessons learned.

Learning Objective(s):
Explain the role project managers can play in bridging the gap between strategy and execution; Recognize opportunities in team structure and governance to leverage innovation which occurs during execution; Formulate clear strategic objectives for clinical trials and ensure that trial designs are optimized to meet these objectives.

Presentation(s) & Speaker(s):
Role of Project Managers in Improving the Effectiveness of Global Product Development
Akhil Agrawal, PhD,PMP
Associate Director
Merck Research Laboratories, United States

Strategy and Operations: Mutually Exclusive or Delicate Balancing Act?
Jaime Baldner
Manager, Clinical Data Management
Genentech, A Member of the Roche Group, United States

Strategic Implementation of Clinical Trials
Raymond G. Starrett, MS
Senior Director, Project Management Operations
Ikaria, Inc., United States

© 2013 DIA